When did Champions Oncology report Q4 2025 earnings?

Champions Oncology (CSBR) reported Q4 2025 earnings on December 15, 2025 after market close.

What were Champions Oncology's Q4 2025 revenue and EPS?

Champions Oncology reported revenue of $15.0M and diluted EPS of $0.02 for Q4 2025.

Did Champions Oncology beat estimates in Q4 2025?

Revenue missed the consensus estimate of $16.4M by $1.4M. EPS missed the consensus estimate of $0.08 by $0.06.

How did Champions Oncology's Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 11.5% from $13.5M a year earlier and diluted EPS declined 60.0% from $0.05.

Where can I find Champions Oncology's Q4 2025 SEC filings?

You can read the 8-K earnings release (0001628280-25-057020) and the 10-Q periodic report (0001628280-25-057082) directly on SEC EDGAR. The filing index links above go to sec.gov.

Champions Oncology CSBR Q4 2025 earnings

Reported December 15, 2025 · After market close

Revenue$15.0MMiss by $1.4M Diluted EPS$0.02Miss by $0.06

Revenue estimate$16.4M

EPS estimate$0.08

Next report

Jul 16, 2026 (In 3 weeks)

Revenue estimate$12.9M

EPS estimate-$0.05

Versus estimates

Revenue

Q1 2026$16.6MMiss by $54.0K

Q4 2025$15.0MMiss by $1.4M

Q3 2025$14.0MMiss by $47.0K Q2 2025$12.4MMiss by $2.3M Q1 2025$17.0MBeat by $5.0M Q4 2024$13.5MBeat by $435.0K

Diluted EPS

Q1 2026-$0.02Miss by $0.11

Q4 2025$0.02Miss by $0.06

Q3 2025-$0.03Miss by $0.04 Q2 2025-$0.13Miss by $0.19 Q1 2025$0.31Beat by $0.32 Q4 2024$0.05Beat by $0.04

Ask the moment Champions Oncology reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Champions Oncology report Q4 2025 earnings?: Champions Oncology (CSBR) reported Q4 2025 earnings on December 15, 2025 after market close.
What were Champions Oncology's Q4 2025 revenue and EPS?: Champions Oncology reported revenue of $15.0M and diluted EPS of $0.02 for Q4 2025.
Did Champions Oncology beat estimates in Q4 2025?: Revenue missed the consensus estimate of $16.4M by $1.4M. EPS missed the consensus estimate of $0.08 by $0.06.
How did Champions Oncology's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 11.5% from $13.5M a year earlier and diluted EPS declined 60.0% from $0.05.
Where can I find Champions Oncology's Q4 2025 SEC filings?: You can read the 8-K earnings release (0001628280-25-057020) and the 10-Q periodic report (0001628280-25-057082) directly on SEC EDGAR. The filing index links above go to sec.gov.